BioWorld Asia

Jan. 28, 2004

Two German Kinase Companies Merge, Bring In EUR11M Financing

MUNICH, Germany - Two young Munich biotechnology companies - Nadag AG and Sireen AG - merged to form Sirenade Pharmaceuticals AG, which will focus on oncology and central nervous system conditions. (BioWorld International) Read More

As GW's Sativex Is Reviewed, Extension-Study Data Grow

Detailed Inflammation Pathway Map To Hasten Drug Discovery

BresaGen Seeking Protection After Talks With Investor Fail

Denmark Eyes North Sea Oil Tax As Source For Research Funding

EU Aiming To Pave Way For Tissue-Engineering Market

Other News To Note

Today's news in brief

BioWorld

BioWorld briefs for Dec. 19, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for Dec. 19, 2025.

Left: Anthony Fauci. Right: Transmission electron micrograph of HIV-1 virus particles

HIV research is close to a cure but far from ending the pandemic

BioWorld

Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...

Apollo’s APL-4098 shows potent antileukemic effects

BioWorld Science

Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.

Illustration of brain with electrical activity background

ABS-1230 controls seizures in KCNT1-driven severe epilepsy

BioWorld Science

Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...